Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing therapy
Dickson R, Bagust A, Boland A, Blundell M, Davis H, Dundar Y, et al.
Record ID 32011000757
English
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/0820001/#/
Year Published:
2011
URL for published report:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/0820001/#/
Requestor:
NIHR Health Technology Assessment programme
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
Pubmed ID:
21967156
MeSH Terms
- Antineoplastic Agents
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Quinazolines
- Erlotinib Hydrochloride
- Protein Kinase Inhibitors
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.